nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—UGT2B7—Epirubicin—uterine cancer	0.0989	0.151	CbGbCtD
Losartan—UGT1A1—Etoposide—uterine cancer	0.0666	0.102	CbGbCtD
Losartan—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0658	0.101	CbGbCtD
Losartan—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0459	0.0701	CbGbCtD
Losartan—CYP3A5—Progesterone—uterine cancer	0.0453	0.0693	CbGbCtD
Losartan—CYP2C8—Progesterone—uterine cancer	0.0436	0.0666	CbGbCtD
Losartan—CYP2C19—Progesterone—uterine cancer	0.0366	0.0559	CbGbCtD
Losartan—CYP1A2—Progesterone—uterine cancer	0.0337	0.0516	CbGbCtD
Losartan—CYP2C9—Progesterone—uterine cancer	0.0304	0.0465	CbGbCtD
Losartan—ABCB1—Progesterone—uterine cancer	0.0295	0.0451	CbGbCtD
Losartan—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0267	0.0408	CbGbCtD
Losartan—ABCB1—Dactinomycin—uterine cancer	0.0234	0.0358	CbGbCtD
Losartan—CYP3A5—Etoposide—uterine cancer	0.0203	0.031	CbGbCtD
Losartan—CYP2C8—Etoposide—uterine cancer	0.0195	0.0298	CbGbCtD
Losartan—CYP3A4—Progesterone—uterine cancer	0.0177	0.027	CbGbCtD
Losartan—CYP1A2—Etoposide—uterine cancer	0.0151	0.0231	CbGbCtD
Losartan—ABCB1—Etoposide—uterine cancer	0.0132	0.0202	CbGbCtD
Losartan—ABCB1—Doxorubicin—uterine cancer	0.009	0.0138	CbGbCtD
Losartan—UGT2B17—epithelium—uterine cancer	0.00819	0.103	CbGeAlD
Losartan—CYP3A4—Etoposide—uterine cancer	0.00791	0.0121	CbGbCtD
Losartan—UGT2B17—endometrium—uterine cancer	0.00734	0.0922	CbGeAlD
Losartan—CYP3A4—Doxorubicin—uterine cancer	0.0054	0.00825	CbGbCtD
Losartan—SLC22A12—renal system—uterine cancer	0.00489	0.0615	CbGeAlD
Losartan—UGT1A10—renal system—uterine cancer	0.00429	0.0539	CbGeAlD
Losartan—AGTR1—artery—uterine cancer	0.00366	0.046	CbGeAlD
Losartan—SLC2A9—renal system—uterine cancer	0.00336	0.0422	CbGeAlD
Losartan—ACE—artery—uterine cancer	0.0027	0.034	CbGeAlD
Losartan—SLC2A9—female reproductive system—uterine cancer	0.00269	0.0338	CbGeAlD
Losartan—SLC2A9—female gonad—uterine cancer	0.00245	0.0308	CbGeAlD
Losartan—AGTR1—myometrium—uterine cancer	0.00177	0.0222	CbGeAlD
Losartan—UGT2B7—renal system—uterine cancer	0.00174	0.0218	CbGeAlD
Losartan—SLC2A9—lymph node—uterine cancer	0.00158	0.0198	CbGeAlD
Losartan—SLCO1B3—vagina—uterine cancer	0.00154	0.0193	CbGeAlD
Losartan—UGT1A1—renal system—uterine cancer	0.00148	0.0185	CbGeAlD
Losartan—UGT2B7—female reproductive system—uterine cancer	0.00139	0.0175	CbGeAlD
Losartan—AGTR1—epithelium—uterine cancer	0.00139	0.0174	CbGeAlD
Losartan—AGTR1—uterine cervix—uterine cancer	0.00138	0.0173	CbGeAlD
Losartan—AGTR1—smooth muscle tissue—uterine cancer	0.00134	0.0168	CbGeAlD
Losartan—AGTR1—decidua—uterine cancer	0.00131	0.0165	CbGeAlD
Losartan—AGTR1—renal system—uterine cancer	0.00129	0.0162	CbGeAlD
Losartan—SLCO1B1—renal system—uterine cancer	0.00123	0.0154	CbGeAlD
Losartan—AGTR1—female reproductive system—uterine cancer	0.00103	0.013	CbGeAlD
Losartan—ACE—epithelium—uterine cancer	0.00103	0.0129	CbGeAlD
Losartan—ACE—smooth muscle tissue—uterine cancer	0.000988	0.0124	CbGeAlD
Losartan—SLCO1B1—female reproductive system—uterine cancer	0.000984	0.0124	CbGeAlD
Losartan—ACE—decidua—uterine cancer	0.000969	0.0122	CbGeAlD
Losartan—ACE—renal system—uterine cancer	0.000951	0.012	CbGeAlD
Losartan—AGTR1—vagina—uterine cancer	0.000933	0.0117	CbGeAlD
Losartan—ACE—endometrium—uterine cancer	0.00092	0.0116	CbGeAlD
Losartan—ACE—mammalian vulva—uterine cancer	0.00089	0.0112	CbGeAlD
Losartan—ACE—female reproductive system—uterine cancer	0.000762	0.00957	CbGeAlD
Losartan—CYP2C8—renal system—uterine cancer	0.000699	0.00877	CbGeAlD
Losartan—ACE—female gonad—uterine cancer	0.000693	0.00871	CbGeAlD
Losartan—CYP2C8—endometrium—uterine cancer	0.000675	0.00848	CbGeAlD
Losartan—CYP3A5—uterine cervix—uterine cancer	0.000674	0.00847	CbGeAlD
Losartan—CYP1A2—renal system—uterine cancer	0.000654	0.00821	CbGeAlD
Losartan—CYP3A5—renal system—uterine cancer	0.00063	0.00792	CbGeAlD
Losartan—AGTR1—lymph node—uterine cancer	0.000604	0.00758	CbGeAlD
Losartan—CYP2C19—vagina—uterine cancer	0.00058	0.00728	CbGeAlD
Losartan—CYP2C8—female reproductive system—uterine cancer	0.000559	0.00703	CbGeAlD
Losartan—CYP2C8—vagina—uterine cancer	0.000506	0.00636	CbGeAlD
Losartan—CYP2C9—female reproductive system—uterine cancer	0.000497	0.00624	CbGeAlD
Losartan—CYP3A4—renal system—uterine cancer	0.000473	0.00594	CbGeAlD
Losartan—ALB—lymph node—uterine cancer	0.000466	0.00585	CbGeAlD
Losartan—ABCB1—myometrium—uterine cancer	0.00046	0.00578	CbGeAlD
Losartan—CYP3A5—female gonad—uterine cancer	0.000459	0.00577	CbGeAlD
Losartan—CYP3A5—vagina—uterine cancer	0.000457	0.00574	CbGeAlD
Losartan—ACE—lymph node—uterine cancer	0.000446	0.0056	CbGeAlD
Losartan—CYP3A4—female reproductive system—uterine cancer	0.000379	0.00476	CbGeAlD
Losartan—ABCB1—epithelium—uterine cancer	0.000361	0.00454	CbGeAlD
Losartan—ABCB1—uterine cervix—uterine cancer	0.000358	0.0045	CbGeAlD
Losartan—ABCB1—decidua—uterine cancer	0.000341	0.00428	CbGeAlD
Losartan—ABCB1—renal system—uterine cancer	0.000335	0.00421	CbGeAlD
Losartan—ABCB1—endometrium—uterine cancer	0.000324	0.00407	CbGeAlD
Losartan—ABCB1—mammalian vulva—uterine cancer	0.000313	0.00393	CbGeAlD
Losartan—ABCB1—uterus—uterine cancer	0.000298	0.00375	CbGeAlD
Losartan—ABCB1—female reproductive system—uterine cancer	0.000268	0.00337	CbGeAlD
Losartan—ABCB1—female gonad—uterine cancer	0.000244	0.00307	CbGeAlD
Losartan—Face oedema—Epirubicin—uterine cancer	0.000244	0.00122	CcSEcCtD
Losartan—Vertigo—Etoposide—uterine cancer	0.000244	0.00122	CcSEcCtD
Losartan—Leukopenia—Etoposide—uterine cancer	0.000243	0.00122	CcSEcCtD
Losartan—ABCB1—vagina—uterine cancer	0.000243	0.00305	CbGeAlD
Losartan—Purpura—Doxorubicin—uterine cancer	0.000242	0.00122	CcSEcCtD
Losartan—Abdominal pain—Dactinomycin—uterine cancer	0.000242	0.00122	CcSEcCtD
Losartan—Body temperature increased—Dactinomycin—uterine cancer	0.000242	0.00122	CcSEcCtD
Losartan—Hypoglycaemia—Doxorubicin—uterine cancer	0.000239	0.0012	CcSEcCtD
Losartan—Loss of consciousness—Etoposide—uterine cancer	0.000238	0.0012	CcSEcCtD
Losartan—Ataxia—Epirubicin—uterine cancer	0.000237	0.00119	CcSEcCtD
Losartan—Cough—Etoposide—uterine cancer	0.000237	0.00119	CcSEcCtD
Losartan—Blood creatinine increased—Epirubicin—uterine cancer	0.000236	0.00119	CcSEcCtD
Losartan—Hyponatraemia—Doxorubicin—uterine cancer	0.000234	0.00118	CcSEcCtD
Losartan—Pain in extremity—Doxorubicin—uterine cancer	0.000234	0.00117	CcSEcCtD
Losartan—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000233	0.00117	CcSEcCtD
Losartan—Dry skin—Epirubicin—uterine cancer	0.000231	0.00116	CcSEcCtD
Losartan—Chest pain—Etoposide—uterine cancer	0.000231	0.00116	CcSEcCtD
Losartan—Orthostatic hypotension—Epirubicin—uterine cancer	0.000231	0.00116	CcSEcCtD
Losartan—Migraine—Doxorubicin—uterine cancer	0.00023	0.00116	CcSEcCtD
Losartan—Discomfort—Etoposide—uterine cancer	0.000228	0.00115	CcSEcCtD
Losartan—Breast disorder—Epirubicin—uterine cancer	0.000228	0.00115	CcSEcCtD
Losartan—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000227	0.00114	CcSEcCtD
Losartan—Face oedema—Doxorubicin—uterine cancer	0.000225	0.00113	CcSEcCtD
Losartan—Hypersensitivity—Dactinomycin—uterine cancer	0.000225	0.00113	CcSEcCtD
Losartan—Gastritis—Epirubicin—uterine cancer	0.000223	0.00112	CcSEcCtD
Losartan—Confusional state—Etoposide—uterine cancer	0.000223	0.00112	CcSEcCtD
Losartan—Muscular weakness—Epirubicin—uterine cancer	0.000223	0.00112	CcSEcCtD
Losartan—Anaphylactic shock—Etoposide—uterine cancer	0.000221	0.00111	CcSEcCtD
Losartan—Infection—Etoposide—uterine cancer	0.00022	0.00111	CcSEcCtD
Losartan—Ataxia—Doxorubicin—uterine cancer	0.00022	0.0011	CcSEcCtD
Losartan—Asthenia—Dactinomycin—uterine cancer	0.000219	0.0011	CcSEcCtD
Losartan—Blood creatinine increased—Doxorubicin—uterine cancer	0.000219	0.0011	CcSEcCtD
Losartan—Influenza—Epirubicin—uterine cancer	0.000218	0.0011	CcSEcCtD
Losartan—Thrombocytopenia—Etoposide—uterine cancer	0.000217	0.00109	CcSEcCtD
Losartan—Tachycardia—Etoposide—uterine cancer	0.000216	0.00109	CcSEcCtD
Losartan—Eosinophilia—Epirubicin—uterine cancer	0.000216	0.00109	CcSEcCtD
Losartan—Dry skin—Doxorubicin—uterine cancer	0.000214	0.00108	CcSEcCtD
Losartan—Hyperhidrosis—Etoposide—uterine cancer	0.000214	0.00108	CcSEcCtD
Losartan—Pancreatitis—Epirubicin—uterine cancer	0.000214	0.00108	CcSEcCtD
Losartan—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000213	0.00107	CcSEcCtD
Losartan—Angina pectoris—Epirubicin—uterine cancer	0.000213	0.00107	CcSEcCtD
Losartan—Breast disorder—Doxorubicin—uterine cancer	0.000211	0.00106	CcSEcCtD
Losartan—Anorexia—Etoposide—uterine cancer	0.000211	0.00106	CcSEcCtD
Losartan—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.00021	0.00106	CcSEcCtD
Losartan—Bronchitis—Epirubicin—uterine cancer	0.00021	0.00105	CcSEcCtD
Losartan—Diarrhoea—Dactinomycin—uterine cancer	0.000209	0.00105	CcSEcCtD
Losartan—Hypotension—Etoposide—uterine cancer	0.000207	0.00104	CcSEcCtD
Losartan—Gastritis—Doxorubicin—uterine cancer	0.000207	0.00104	CcSEcCtD
Losartan—Muscular weakness—Doxorubicin—uterine cancer	0.000206	0.00104	CcSEcCtD
Losartan—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000203	0.00102	CcSEcCtD
Losartan—Influenza—Doxorubicin—uterine cancer	0.000202	0.00101	CcSEcCtD
Losartan—Pollakiuria—Epirubicin—uterine cancer	0.000202	0.00101	CcSEcCtD
Losartan—Eosinophilia—Doxorubicin—uterine cancer	0.0002	0.001	CcSEcCtD
Losartan—Photosensitivity reaction—Epirubicin—uterine cancer	0.000199	0.001	CcSEcCtD
Losartan—Paraesthesia—Etoposide—uterine cancer	0.000199	0.000999	CcSEcCtD
Losartan—Weight increased—Epirubicin—uterine cancer	0.000199	0.000998	CcSEcCtD
Losartan—Pancreatitis—Doxorubicin—uterine cancer	0.000198	0.000995	CcSEcCtD
Losartan—Dyspnoea—Etoposide—uterine cancer	0.000197	0.000992	CcSEcCtD
Losartan—Hyperglycaemia—Epirubicin—uterine cancer	0.000197	0.000989	CcSEcCtD
Losartan—Somnolence—Etoposide—uterine cancer	0.000197	0.000989	CcSEcCtD
Losartan—Angina pectoris—Doxorubicin—uterine cancer	0.000197	0.000988	CcSEcCtD
Losartan—Pneumonia—Epirubicin—uterine cancer	0.000196	0.000983	CcSEcCtD
Losartan—Vomiting—Dactinomycin—uterine cancer	0.000194	0.000977	CcSEcCtD
Losartan—Bronchitis—Doxorubicin—uterine cancer	0.000194	0.000976	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000193	0.000969	CcSEcCtD
Losartan—Rash—Dactinomycin—uterine cancer	0.000193	0.000969	CcSEcCtD
Losartan—Decreased appetite—Etoposide—uterine cancer	0.000192	0.000967	CcSEcCtD
Losartan—Renal failure—Epirubicin—uterine cancer	0.000191	0.000961	CcSEcCtD
Losartan—Fatigue—Etoposide—uterine cancer	0.000191	0.000959	CcSEcCtD
Losartan—Neuropathy peripheral—Epirubicin—uterine cancer	0.000191	0.000958	CcSEcCtD
Losartan—Jaundice—Epirubicin—uterine cancer	0.00019	0.000953	CcSEcCtD
Losartan—Pain—Etoposide—uterine cancer	0.000189	0.000951	CcSEcCtD
Losartan—Constipation—Etoposide—uterine cancer	0.000189	0.000951	CcSEcCtD
Losartan—Conjunctivitis—Epirubicin—uterine cancer	0.000189	0.00095	CcSEcCtD
Losartan—Urinary tract infection—Epirubicin—uterine cancer	0.000189	0.00095	CcSEcCtD
Losartan—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000188	0.000943	CcSEcCtD
Losartan—Sweating—Epirubicin—uterine cancer	0.000186	0.000937	CcSEcCtD
Losartan—Pollakiuria—Doxorubicin—uterine cancer	0.000186	0.000937	CcSEcCtD
Losartan—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000184	0.000926	CcSEcCtD
Losartan—Weight increased—Doxorubicin—uterine cancer	0.000184	0.000923	CcSEcCtD
Losartan—Epistaxis—Epirubicin—uterine cancer	0.000183	0.000922	CcSEcCtD
Losartan—Sinusitis—Epirubicin—uterine cancer	0.000182	0.000917	CcSEcCtD
Losartan—Feeling abnormal—Etoposide—uterine cancer	0.000182	0.000917	CcSEcCtD
Losartan—Hyperglycaemia—Doxorubicin—uterine cancer	0.000182	0.000915	CcSEcCtD
Losartan—Nausea—Dactinomycin—uterine cancer	0.000182	0.000913	CcSEcCtD
Losartan—Agranulocytosis—Epirubicin—uterine cancer	0.000182	0.000912	CcSEcCtD
Losartan—Pneumonia—Doxorubicin—uterine cancer	0.000181	0.00091	CcSEcCtD
Losartan—Gastrointestinal pain—Etoposide—uterine cancer	0.000181	0.00091	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000178	0.000897	CcSEcCtD
Losartan—Renal failure—Doxorubicin—uterine cancer	0.000177	0.000889	CcSEcCtD
Losartan—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000176	0.000887	CcSEcCtD
Losartan—Urticaria—Etoposide—uterine cancer	0.000176	0.000884	CcSEcCtD
Losartan—Jaundice—Doxorubicin—uterine cancer	0.000175	0.000882	CcSEcCtD
Losartan—Rhinitis—Epirubicin—uterine cancer	0.000175	0.00088	CcSEcCtD
Losartan—Abdominal pain—Etoposide—uterine cancer	0.000175	0.000879	CcSEcCtD
Losartan—Body temperature increased—Etoposide—uterine cancer	0.000175	0.000879	CcSEcCtD
Losartan—Conjunctivitis—Doxorubicin—uterine cancer	0.000175	0.000879	CcSEcCtD
Losartan—Urinary tract infection—Doxorubicin—uterine cancer	0.000175	0.000879	CcSEcCtD
Losartan—Hepatitis—Epirubicin—uterine cancer	0.000175	0.000878	CcSEcCtD
Losartan—Hypoaesthesia—Epirubicin—uterine cancer	0.000174	0.000873	CcSEcCtD
Losartan—Pharyngitis—Epirubicin—uterine cancer	0.000173	0.000871	CcSEcCtD
Losartan—Sweating—Doxorubicin—uterine cancer	0.000173	0.000867	CcSEcCtD
Losartan—Epistaxis—Doxorubicin—uterine cancer	0.00017	0.000853	CcSEcCtD
Losartan—Sinusitis—Doxorubicin—uterine cancer	0.000169	0.000849	CcSEcCtD
Losartan—Agranulocytosis—Doxorubicin—uterine cancer	0.000168	0.000844	CcSEcCtD
Losartan—Erythema multiforme—Epirubicin—uterine cancer	0.000165	0.00083	CcSEcCtD
Losartan—Hypersensitivity—Etoposide—uterine cancer	0.000163	0.00082	CcSEcCtD
Losartan—Tinnitus—Epirubicin—uterine cancer	0.000163	0.000818	CcSEcCtD
Losartan—Flushing—Epirubicin—uterine cancer	0.000162	0.000815	CcSEcCtD
Losartan—Rhinitis—Doxorubicin—uterine cancer	0.000162	0.000814	CcSEcCtD
Losartan—Hepatitis—Doxorubicin—uterine cancer	0.000162	0.000812	CcSEcCtD
Losartan—Hypoaesthesia—Doxorubicin—uterine cancer	0.000161	0.000808	CcSEcCtD
Losartan—Pharyngitis—Doxorubicin—uterine cancer	0.00016	0.000806	CcSEcCtD
Losartan—Asthenia—Etoposide—uterine cancer	0.000159	0.000798	CcSEcCtD
Losartan—Angiopathy—Epirubicin—uterine cancer	0.000158	0.000796	CcSEcCtD
Losartan—ABCB1—lymph node—uterine cancer	0.000157	0.00197	CbGeAlD
Losartan—Pruritus—Etoposide—uterine cancer	0.000157	0.000787	CcSEcCtD
Losartan—Arrhythmia—Epirubicin—uterine cancer	0.000156	0.000784	CcSEcCtD
Losartan—Alopecia—Epirubicin—uterine cancer	0.000154	0.000776	CcSEcCtD
Losartan—Erythema multiforme—Doxorubicin—uterine cancer	0.000153	0.000768	CcSEcCtD
Losartan—Erythema—Epirubicin—uterine cancer	0.000152	0.000764	CcSEcCtD
Losartan—Diarrhoea—Etoposide—uterine cancer	0.000151	0.000761	CcSEcCtD
Losartan—Tinnitus—Doxorubicin—uterine cancer	0.000151	0.000757	CcSEcCtD
Losartan—Flushing—Doxorubicin—uterine cancer	0.00015	0.000754	CcSEcCtD
Losartan—Flatulence—Epirubicin—uterine cancer	0.00015	0.000753	CcSEcCtD
Losartan—Tension—Epirubicin—uterine cancer	0.000149	0.00075	CcSEcCtD
Losartan—Dysgeusia—Epirubicin—uterine cancer	0.000149	0.000748	CcSEcCtD
Losartan—Nervousness—Epirubicin—uterine cancer	0.000148	0.000742	CcSEcCtD
Losartan—Back pain—Epirubicin—uterine cancer	0.000147	0.000739	CcSEcCtD
Losartan—Angiopathy—Doxorubicin—uterine cancer	0.000147	0.000737	CcSEcCtD
Losartan—Dizziness—Etoposide—uterine cancer	0.000146	0.000736	CcSEcCtD
Losartan—Muscle spasms—Epirubicin—uterine cancer	0.000146	0.000735	CcSEcCtD
Losartan—Arrhythmia—Doxorubicin—uterine cancer	0.000144	0.000726	CcSEcCtD
Losartan—Vision blurred—Epirubicin—uterine cancer	0.000143	0.00072	CcSEcCtD
Losartan—Alopecia—Doxorubicin—uterine cancer	0.000143	0.000718	CcSEcCtD
Losartan—Ill-defined disorder—Epirubicin—uterine cancer	0.000141	0.000709	CcSEcCtD
Losartan—Vomiting—Etoposide—uterine cancer	0.000141	0.000707	CcSEcCtD
Losartan—Erythema—Doxorubicin—uterine cancer	0.000141	0.000707	CcSEcCtD
Losartan—Anaemia—Epirubicin—uterine cancer	0.00014	0.000706	CcSEcCtD
Losartan—Agitation—Epirubicin—uterine cancer	0.00014	0.000702	CcSEcCtD
Losartan—Rash—Etoposide—uterine cancer	0.00014	0.000701	CcSEcCtD
Losartan—Dermatitis—Etoposide—uterine cancer	0.000139	0.000701	CcSEcCtD
Losartan—Headache—Etoposide—uterine cancer	0.000139	0.000697	CcSEcCtD
Losartan—Flatulence—Doxorubicin—uterine cancer	0.000139	0.000697	CcSEcCtD
Losartan—Tension—Doxorubicin—uterine cancer	0.000138	0.000694	CcSEcCtD
Losartan—Dysgeusia—Doxorubicin—uterine cancer	0.000138	0.000692	CcSEcCtD
Losartan—Malaise—Epirubicin—uterine cancer	0.000137	0.000689	CcSEcCtD
Losartan—Nervousness—Doxorubicin—uterine cancer	0.000137	0.000687	CcSEcCtD
Losartan—Vertigo—Epirubicin—uterine cancer	0.000137	0.000687	CcSEcCtD
Losartan—Syncope—Epirubicin—uterine cancer	0.000136	0.000685	CcSEcCtD
Losartan—Leukopenia—Epirubicin—uterine cancer	0.000136	0.000684	CcSEcCtD
Losartan—Back pain—Doxorubicin—uterine cancer	0.000136	0.000684	CcSEcCtD
Losartan—Muscle spasms—Doxorubicin—uterine cancer	0.000135	0.00068	CcSEcCtD
Losartan—Palpitations—Epirubicin—uterine cancer	0.000134	0.000675	CcSEcCtD
Losartan—Loss of consciousness—Epirubicin—uterine cancer	0.000134	0.000672	CcSEcCtD
Losartan—Cough—Epirubicin—uterine cancer	0.000133	0.000667	CcSEcCtD
Losartan—Vision blurred—Doxorubicin—uterine cancer	0.000133	0.000666	CcSEcCtD
Losartan—Nausea—Etoposide—uterine cancer	0.000131	0.000661	CcSEcCtD
Losartan—Ill-defined disorder—Doxorubicin—uterine cancer	0.00013	0.000656	CcSEcCtD
Losartan—Anaemia—Doxorubicin—uterine cancer	0.00013	0.000653	CcSEcCtD
Losartan—Chest pain—Epirubicin—uterine cancer	0.000129	0.000651	CcSEcCtD
Losartan—Arthralgia—Epirubicin—uterine cancer	0.000129	0.000651	CcSEcCtD
Losartan—Myalgia—Epirubicin—uterine cancer	0.000129	0.000651	CcSEcCtD
Losartan—Agitation—Doxorubicin—uterine cancer	0.000129	0.00065	CcSEcCtD
Losartan—Anxiety—Epirubicin—uterine cancer	0.000129	0.000648	CcSEcCtD
Losartan—Discomfort—Epirubicin—uterine cancer	0.000128	0.000643	CcSEcCtD
Losartan—Malaise—Doxorubicin—uterine cancer	0.000127	0.000638	CcSEcCtD
Losartan—Dry mouth—Epirubicin—uterine cancer	0.000127	0.000636	CcSEcCtD
Losartan—Vertigo—Doxorubicin—uterine cancer	0.000126	0.000635	CcSEcCtD
Losartan—Syncope—Doxorubicin—uterine cancer	0.000126	0.000634	CcSEcCtD
Losartan—Leukopenia—Doxorubicin—uterine cancer	0.000126	0.000633	CcSEcCtD
Losartan—Confusional state—Epirubicin—uterine cancer	0.000125	0.000629	CcSEcCtD
Losartan—Palpitations—Doxorubicin—uterine cancer	0.000124	0.000625	CcSEcCtD
Losartan—Anaphylactic shock—Epirubicin—uterine cancer	0.000124	0.000624	CcSEcCtD
Losartan—Oedema—Epirubicin—uterine cancer	0.000124	0.000624	CcSEcCtD
Losartan—Loss of consciousness—Doxorubicin—uterine cancer	0.000124	0.000621	CcSEcCtD
Losartan—Infection—Epirubicin—uterine cancer	0.000123	0.00062	CcSEcCtD
Losartan—Cough—Doxorubicin—uterine cancer	0.000123	0.000617	CcSEcCtD
Losartan—Shock—Epirubicin—uterine cancer	0.000122	0.000614	CcSEcCtD
Losartan—Nervous system disorder—Epirubicin—uterine cancer	0.000122	0.000612	CcSEcCtD
Losartan—Thrombocytopenia—Epirubicin—uterine cancer	0.000121	0.000611	CcSEcCtD
Losartan—Tachycardia—Epirubicin—uterine cancer	0.000121	0.000609	CcSEcCtD
Losartan—Hyperhidrosis—Epirubicin—uterine cancer	0.00012	0.000603	CcSEcCtD
Losartan—Myalgia—Doxorubicin—uterine cancer	0.00012	0.000602	CcSEcCtD
Losartan—Chest pain—Doxorubicin—uterine cancer	0.00012	0.000602	CcSEcCtD
Losartan—Arthralgia—Doxorubicin—uterine cancer	0.00012	0.000602	CcSEcCtD
Losartan—Anxiety—Doxorubicin—uterine cancer	0.000119	0.0006	CcSEcCtD
Losartan—Discomfort—Doxorubicin—uterine cancer	0.000118	0.000595	CcSEcCtD
Losartan—Anorexia—Epirubicin—uterine cancer	0.000118	0.000594	CcSEcCtD
Losartan—Dry mouth—Doxorubicin—uterine cancer	0.000117	0.000589	CcSEcCtD
Losartan—Hypotension—Epirubicin—uterine cancer	0.000116	0.000583	CcSEcCtD
Losartan—Confusional state—Doxorubicin—uterine cancer	0.000116	0.000582	CcSEcCtD
Losartan—Oedema—Doxorubicin—uterine cancer	0.000115	0.000577	CcSEcCtD
Losartan—Anaphylactic shock—Doxorubicin—uterine cancer	0.000115	0.000577	CcSEcCtD
Losartan—Infection—Doxorubicin—uterine cancer	0.000114	0.000573	CcSEcCtD
Losartan—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000113	0.000568	CcSEcCtD
Losartan—Shock—Doxorubicin—uterine cancer	0.000113	0.000568	CcSEcCtD
Losartan—Nervous system disorder—Doxorubicin—uterine cancer	0.000113	0.000566	CcSEcCtD
Losartan—Thrombocytopenia—Doxorubicin—uterine cancer	0.000112	0.000565	CcSEcCtD
Losartan—Insomnia—Epirubicin—uterine cancer	0.000112	0.000564	CcSEcCtD
Losartan—Tachycardia—Doxorubicin—uterine cancer	0.000112	0.000563	CcSEcCtD
Losartan—Paraesthesia—Epirubicin—uterine cancer	0.000111	0.00056	CcSEcCtD
Losartan—Hyperhidrosis—Doxorubicin—uterine cancer	0.000111	0.000558	CcSEcCtD
Losartan—Dyspnoea—Epirubicin—uterine cancer	0.000111	0.000556	CcSEcCtD
Losartan—Somnolence—Epirubicin—uterine cancer	0.00011	0.000554	CcSEcCtD
Losartan—Anorexia—Doxorubicin—uterine cancer	0.000109	0.00055	CcSEcCtD
Losartan—Dyspepsia—Epirubicin—uterine cancer	0.000109	0.000549	CcSEcCtD
Losartan—Decreased appetite—Epirubicin—uterine cancer	0.000108	0.000542	CcSEcCtD
Losartan—Hypotension—Doxorubicin—uterine cancer	0.000107	0.000539	CcSEcCtD
Losartan—Fatigue—Epirubicin—uterine cancer	0.000107	0.000538	CcSEcCtD
Losartan—Pain—Epirubicin—uterine cancer	0.000106	0.000533	CcSEcCtD
Losartan—Constipation—Epirubicin—uterine cancer	0.000106	0.000533	CcSEcCtD
Losartan—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000105	0.000526	CcSEcCtD
Losartan—Insomnia—Doxorubicin—uterine cancer	0.000104	0.000522	CcSEcCtD
Losartan—Paraesthesia—Doxorubicin—uterine cancer	0.000103	0.000518	CcSEcCtD
Losartan—Dyspnoea—Doxorubicin—uterine cancer	0.000102	0.000514	CcSEcCtD
Losartan—Feeling abnormal—Epirubicin—uterine cancer	0.000102	0.000514	CcSEcCtD
Losartan—Somnolence—Doxorubicin—uterine cancer	0.000102	0.000513	CcSEcCtD
Losartan—Gastrointestinal pain—Epirubicin—uterine cancer	0.000101	0.00051	CcSEcCtD
Losartan—Dyspepsia—Doxorubicin—uterine cancer	0.000101	0.000508	CcSEcCtD
Losartan—Decreased appetite—Doxorubicin—uterine cancer	9.98e-05	0.000502	CcSEcCtD
Losartan—Fatigue—Doxorubicin—uterine cancer	9.9e-05	0.000497	CcSEcCtD
Losartan—Urticaria—Epirubicin—uterine cancer	9.86e-05	0.000495	CcSEcCtD
Losartan—Constipation—Doxorubicin—uterine cancer	9.82e-05	0.000493	CcSEcCtD
Losartan—Pain—Doxorubicin—uterine cancer	9.82e-05	0.000493	CcSEcCtD
Losartan—Abdominal pain—Epirubicin—uterine cancer	9.81e-05	0.000493	CcSEcCtD
Losartan—Body temperature increased—Epirubicin—uterine cancer	9.81e-05	0.000493	CcSEcCtD
Losartan—Feeling abnormal—Doxorubicin—uterine cancer	9.46e-05	0.000476	CcSEcCtD
Losartan—Gastrointestinal pain—Doxorubicin—uterine cancer	9.39e-05	0.000472	CcSEcCtD
Losartan—Hypersensitivity—Epirubicin—uterine cancer	9.14e-05	0.000459	CcSEcCtD
Losartan—Urticaria—Doxorubicin—uterine cancer	9.12e-05	0.000458	CcSEcCtD
Losartan—Abdominal pain—Doxorubicin—uterine cancer	9.07e-05	0.000456	CcSEcCtD
Losartan—Body temperature increased—Doxorubicin—uterine cancer	9.07e-05	0.000456	CcSEcCtD
Losartan—Asthenia—Epirubicin—uterine cancer	8.9e-05	0.000447	CcSEcCtD
Losartan—Pruritus—Epirubicin—uterine cancer	8.78e-05	0.000441	CcSEcCtD
Losartan—Diarrhoea—Epirubicin—uterine cancer	8.49e-05	0.000427	CcSEcCtD
Losartan—Hypersensitivity—Doxorubicin—uterine cancer	8.46e-05	0.000425	CcSEcCtD
Losartan—Asthenia—Doxorubicin—uterine cancer	8.24e-05	0.000414	CcSEcCtD
Losartan—Dizziness—Epirubicin—uterine cancer	8.2e-05	0.000412	CcSEcCtD
Losartan—Pruritus—Doxorubicin—uterine cancer	8.12e-05	0.000408	CcSEcCtD
Losartan—Vomiting—Epirubicin—uterine cancer	7.89e-05	0.000397	CcSEcCtD
Losartan—Diarrhoea—Doxorubicin—uterine cancer	7.85e-05	0.000395	CcSEcCtD
Losartan—Rash—Epirubicin—uterine cancer	7.82e-05	0.000393	CcSEcCtD
Losartan—Dermatitis—Epirubicin—uterine cancer	7.81e-05	0.000393	CcSEcCtD
Losartan—Headache—Epirubicin—uterine cancer	7.77e-05	0.000391	CcSEcCtD
Losartan—Dizziness—Doxorubicin—uterine cancer	7.59e-05	0.000382	CcSEcCtD
Losartan—Nausea—Epirubicin—uterine cancer	7.37e-05	0.00037	CcSEcCtD
Losartan—Vomiting—Doxorubicin—uterine cancer	7.3e-05	0.000367	CcSEcCtD
Losartan—Rash—Doxorubicin—uterine cancer	7.24e-05	0.000364	CcSEcCtD
Losartan—Dermatitis—Doxorubicin—uterine cancer	7.23e-05	0.000363	CcSEcCtD
Losartan—Headache—Doxorubicin—uterine cancer	7.19e-05	0.000361	CcSEcCtD
Losartan—Nausea—Doxorubicin—uterine cancer	6.82e-05	0.000343	CcSEcCtD
Losartan—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	2.91e-05	0.000434	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—STAR—uterine cancer	2.89e-05	0.000431	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—AKR1B1—uterine cancer	2.89e-05	0.000431	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.87e-05	0.000428	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—STK11—uterine cancer	2.86e-05	0.000426	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—CYP19A1—uterine cancer	2.86e-05	0.000426	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—RRM2—uterine cancer	2.85e-05	0.000425	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—CYP11A1—uterine cancer	2.85e-05	0.000424	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.84e-05	0.000423	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—NDUFB11—uterine cancer	2.82e-05	0.00042	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—SRD5A2—uterine cancer	2.82e-05	0.00042	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—DCN—uterine cancer	2.77e-05	0.000412	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.74e-05	0.000408	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—STK11—uterine cancer	2.74e-05	0.000408	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CCL2—uterine cancer	2.72e-05	0.000406	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—AKR1C3—uterine cancer	2.69e-05	0.0004	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.68e-05	0.000399	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—CYP11A1—uterine cancer	2.61e-05	0.000389	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.59e-05	0.000385	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—STK11—uterine cancer	2.58e-05	0.000384	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—CYP19A1—uterine cancer	2.58e-05	0.000384	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—SOCS3—uterine cancer	2.56e-05	0.000382	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.56e-05	0.000381	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	2.53e-05	0.000377	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—STAR—uterine cancer	2.5e-05	0.000373	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—AKR1B1—uterine cancer	2.5e-05	0.000373	CbGpPWpGaD
Losartan—ALB—Metabolism—AKR1B1—uterine cancer	2.49e-05	0.000371	CbGpPWpGaD
Losartan—ALB—Metabolism—STAR—uterine cancer	2.49e-05	0.000371	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.48e-05	0.000369	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—AKR1C3—uterine cancer	2.46e-05	0.000367	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.46e-05	0.000367	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CDKN2B—uterine cancer	2.45e-05	0.000366	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SRD5A2—uterine cancer	2.41e-05	0.000359	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—NDUFB11—uterine cancer	2.41e-05	0.000359	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IGF1R—uterine cancer	2.38e-05	0.000355	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—CXCL8—uterine cancer	2.37e-05	0.000353	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	2.34e-05	0.000349	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.34e-05	0.000349	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—MTHFR—uterine cancer	2.28e-05	0.000339	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—POLD1—uterine cancer	2.27e-05	0.000338	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—SMAD3—uterine cancer	2.24e-05	0.000334	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—AKR1B1—uterine cancer	2.23e-05	0.000333	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—STAR—uterine cancer	2.23e-05	0.000333	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	2.21e-05	0.00033	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.21e-05	0.000329	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.21e-05	0.000329	CbGpPWpGaD
Losartan—ABCB1—Metabolism—AKR1B1—uterine cancer	2.18e-05	0.000325	CbGpPWpGaD
Losartan—ABCB1—Metabolism—STAR—uterine cancer	2.18e-05	0.000325	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	2.16e-05	0.000322	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CXCL8—uterine cancer	2.15e-05	0.000321	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—MTHFR—uterine cancer	2.15e-05	0.00032	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—FGFR2—uterine cancer	2.14e-05	0.000318	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—AKR1C1—uterine cancer	2.12e-05	0.000316	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—CYP19A1—uterine cancer	2.09e-05	0.000312	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—STK11—uterine cancer	2.09e-05	0.000312	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	2.06e-05	0.000307	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—AKR1B1—uterine cancer	2.04e-05	0.000304	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—STAR—uterine cancer	2.04e-05	0.000304	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.01e-05	0.0003	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	1.98e-05	0.000295	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—POLD1—uterine cancer	1.96e-05	0.000293	CbGpPWpGaD
Losartan—ALB—Metabolism—POLD1—uterine cancer	1.95e-05	0.000291	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.95e-05	0.000291	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—MTHFR—uterine cancer	1.94e-05	0.000289	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—STK11—uterine cancer	1.92e-05	0.000286	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—CYP19A1—uterine cancer	1.92e-05	0.000286	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—RRM2—uterine cancer	1.89e-05	0.000282	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.89e-05	0.000282	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.86e-05	0.000277	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.86e-05	0.000277	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.84e-05	0.000274	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—DCN—uterine cancer	1.84e-05	0.000274	CbGpPWpGaD
Losartan—ALB—Metabolism—AKR1C1—uterine cancer	1.83e-05	0.000272	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—ESR1—uterine cancer	1.83e-05	0.000272	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.8e-05	0.000268	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—POLD1—uterine cancer	1.75e-05	0.000261	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.74e-05	0.00026	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—STAR—uterine cancer	1.74e-05	0.00026	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CYP11A1—uterine cancer	1.73e-05	0.000258	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—NRAS—uterine cancer	1.73e-05	0.000257	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.72e-05	0.000257	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.72e-05	0.000256	CbGpPWpGaD
Losartan—ABCB1—Metabolism—POLD1—uterine cancer	1.71e-05	0.000255	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.66e-05	0.000247	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.64e-05	0.000244	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—RRM2—uterine cancer	1.64e-05	0.000244	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—AKR1C3—uterine cancer	1.63e-05	0.000243	CbGpPWpGaD
Losartan—ALB—Metabolism—RRM2—uterine cancer	1.63e-05	0.000243	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCL2—uterine cancer	1.61e-05	0.00024	CbGpPWpGaD
Losartan—ABCB1—Metabolism—AKR1C1—uterine cancer	1.6e-05	0.000239	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—POLD1—uterine cancer	1.6e-05	0.000238	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—DCN—uterine cancer	1.59e-05	0.000237	CbGpPWpGaD
Losartan—ALB—Metabolism—DCN—uterine cancer	1.58e-05	0.000236	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—MTHFR—uterine cancer	1.57e-05	0.000234	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	1.55e-05	0.000231	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.52e-05	0.000227	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—PIK3CA—uterine cancer	1.5e-05	0.000224	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.5e-05	0.000223	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.5e-05	0.000223	CbGpPWpGaD
Losartan—ALB—Metabolism—CYP11A1—uterine cancer	1.49e-05	0.000222	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—KRAS—uterine cancer	1.49e-05	0.000222	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.47e-05	0.00022	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—RRM2—uterine cancer	1.46e-05	0.000218	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—MTHFR—uterine cancer	1.44e-05	0.000215	CbGpPWpGaD
Losartan—ABCB1—Metabolism—RRM2—uterine cancer	1.43e-05	0.000213	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—DCN—uterine cancer	1.42e-05	0.000212	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.41e-05	0.000211	CbGpPWpGaD
Losartan—ALB—Metabolism—AKR1C3—uterine cancer	1.41e-05	0.00021	CbGpPWpGaD
Losartan—ABCB1—Metabolism—DCN—uterine cancer	1.39e-05	0.000206	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—POLD1—uterine cancer	1.37e-05	0.000204	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—PIK3CA—uterine cancer	1.37e-05	0.000204	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—STAR—uterine cancer	1.34e-05	0.0002	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.34e-05	0.0002	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—ERBB2—uterine cancer	1.34e-05	0.0002	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CYP11A1—uterine cancer	1.34e-05	0.000199	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—RRM2—uterine cancer	1.33e-05	0.000199	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CYP11A1—uterine cancer	1.31e-05	0.000195	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—DCN—uterine cancer	1.29e-05	0.000193	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—AKR1C1—uterine cancer	1.28e-05	0.000191	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CYP19A1—uterine cancer	1.27e-05	0.00019	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—STK11—uterine cancer	1.27e-05	0.00019	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CXCL8—uterine cancer	1.27e-05	0.00019	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.27e-05	0.000189	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PTEN—uterine cancer	1.27e-05	0.000189	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—HRAS—uterine cancer	1.26e-05	0.000188	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	1.26e-05	0.000188	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—AKR1C3—uterine cancer	1.26e-05	0.000188	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.24e-05	0.000185	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CDKN1B—uterine cancer	1.24e-05	0.000185	CbGpPWpGaD
Losartan—ABCB1—Metabolism—AKR1C3—uterine cancer	1.23e-05	0.000184	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—AKT1—uterine cancer	1.23e-05	0.000183	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.22e-05	0.000182	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—EP300—uterine cancer	1.21e-05	0.00018	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PTEN—uterine cancer	1.19e-05	0.000178	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CTNNB1—uterine cancer	1.17e-05	0.000175	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—AKR1C3—uterine cancer	1.15e-05	0.000172	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PTEN—uterine cancer	1.14e-05	0.00017	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—RRM2—uterine cancer	1.14e-05	0.00017	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—EP300—uterine cancer	1.14e-05	0.00017	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—AKT1—uterine cancer	1.12e-05	0.000166	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—DCN—uterine cancer	1.11e-05	0.000165	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—STK11—uterine cancer	1.1e-05	0.000164	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CYP19A1—uterine cancer	1.1e-05	0.000164	CbGpPWpGaD
Losartan—ALB—Metabolism—STK11—uterine cancer	1.1e-05	0.000163	CbGpPWpGaD
Losartan—ALB—Metabolism—CYP19A1—uterine cancer	1.1e-05	0.000163	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—EP300—uterine cancer	1.09e-05	0.000163	CbGpPWpGaD
Losartan—ALB—Hemostasis—EP300—uterine cancer	1.08e-05	0.000161	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PTEN—uterine cancer	1.08e-05	0.000161	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—POLD1—uterine cancer	1.05e-05	0.000157	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP11A1—uterine cancer	1.04e-05	0.000155	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.03e-05	0.000154	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—VEGFA—uterine cancer	1.03e-05	0.000154	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.03e-05	0.000153	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—EP300—uterine cancer	1.03e-05	0.000153	CbGpPWpGaD
Losartan—ALB—Hemostasis—VEGFA—uterine cancer	1.02e-05	0.000152	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—NRAS—uterine cancer	1.02e-05	0.000152	CbGpPWpGaD
Losartan—ALB—Hemostasis—NRAS—uterine cancer	1.01e-05	0.00015	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.87e-06	0.000147	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AKR1C1—uterine cancer	9.86e-06	0.000147	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—AKR1C3—uterine cancer	9.84e-06	0.000147	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CYP19A1—uterine cancer	9.84e-06	0.000147	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—STK11—uterine cancer	9.84e-06	0.000147	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.81e-06	0.000146	CbGpPWpGaD
Losartan—ABCB1—Metabolism—STK11—uterine cancer	9.6e-06	0.000143	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CYP19A1—uterine cancer	9.6e-06	0.000143	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—MTHFR—uterine cancer	9.56e-06	0.000143	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.24e-06	0.000138	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYP19A1—uterine cancer	8.97e-06	0.000134	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—STK11—uterine cancer	8.97e-06	0.000134	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PIK3CA—uterine cancer	8.94e-06	0.000133	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.81e-06	0.000131	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—RRM2—uterine cancer	8.79e-06	0.000131	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—KRAS—uterine cancer	8.78e-06	0.000131	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PTEN—uterine cancer	8.75e-06	0.00013	CbGpPWpGaD
Losartan—ALB—Hemostasis—KRAS—uterine cancer	8.68e-06	0.000129	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—DCN—uterine cancer	8.54e-06	0.000127	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.42e-06	0.000126	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PIK3CA—uterine cancer	8.42e-06	0.000125	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—EP300—uterine cancer	8.35e-06	0.000124	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—MTHFR—uterine cancer	8.28e-06	0.000123	CbGpPWpGaD
Losartan—ALB—Metabolism—MTHFR—uterine cancer	8.24e-06	0.000123	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PIK3CA—uterine cancer	8.07e-06	0.00012	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP11A1—uterine cancer	8.04e-06	0.00012	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.03e-06	0.00012	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PTEN—uterine cancer	8.02e-06	0.00012	CbGpPWpGaD
Losartan—ALB—Hemostasis—PIK3CA—uterine cancer	7.97e-06	0.000119	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TP53—uterine cancer	7.81e-06	0.000116	CbGpPWpGaD
Losartan—ALB—Hemostasis—TP53—uterine cancer	7.71e-06	0.000115	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP19A1—uterine cancer	7.67e-06	0.000114	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—STK11—uterine cancer	7.67e-06	0.000114	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—EP300—uterine cancer	7.65e-06	0.000114	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PIK3CA—uterine cancer	7.6e-06	0.000113	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AKR1C3—uterine cancer	7.59e-06	0.000113	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—HRAS—uterine cancer	7.47e-06	0.000111	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—MTHFR—uterine cancer	7.39e-06	0.00011	CbGpPWpGaD
Losartan—ALB—Hemostasis—HRAS—uterine cancer	7.38e-06	0.00011	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.3e-06	0.000109	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—AKT1—uterine cancer	7.3e-06	0.000109	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.26e-06	0.000108	CbGpPWpGaD
Losartan—ABCB1—Metabolism—MTHFR—uterine cancer	7.22e-06	0.000108	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.2e-06	0.000107	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—AKT1—uterine cancer	6.88e-06	0.000103	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.86e-06	0.000102	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—MTHFR—uterine cancer	6.74e-06	0.0001	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—AKT1—uterine cancer	6.59e-06	9.82e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.52e-06	9.71e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—AKT1—uterine cancer	6.51e-06	9.71e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—AKT1—uterine cancer	6.21e-06	9.25e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PIK3CA—uterine cancer	6.17e-06	9.2e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.94e-06	8.85e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—STK11—uterine cancer	5.92e-06	8.82e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP19A1—uterine cancer	5.92e-06	8.82e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—MTHFR—uterine cancer	5.76e-06	8.59e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CA—uterine cancer	5.66e-06	8.43e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PTEN—uterine cancer	5.32e-06	7.93e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.08e-06	7.57e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—EP300—uterine cancer	5.07e-06	7.56e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—AKT1—uterine cancer	5.04e-06	7.52e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—AKT1—uterine cancer	4.62e-06	6.89e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PTEN—uterine cancer	4.61e-06	6.87e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PTEN—uterine cancer	4.58e-06	6.83e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—MTHFR—uterine cancer	4.45e-06	6.63e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—EP300—uterine cancer	4.39e-06	6.55e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—EP300—uterine cancer	4.37e-06	6.51e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PTEN—uterine cancer	4.11e-06	6.13e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PTEN—uterine cancer	4.01e-06	5.98e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—EP300—uterine cancer	3.92e-06	5.85e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—EP300—uterine cancer	3.83e-06	5.71e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CA—uterine cancer	3.75e-06	5.59e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PTEN—uterine cancer	3.75e-06	5.59e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—EP300—uterine cancer	3.58e-06	5.33e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CA—uterine cancer	3.25e-06	4.84e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CA—uterine cancer	3.23e-06	4.82e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PTEN—uterine cancer	3.2e-06	4.78e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—AKT1—uterine cancer	3.07e-06	4.57e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—EP300—uterine cancer	3.06e-06	4.56e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CA—uterine cancer	2.9e-06	4.32e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CA—uterine cancer	2.83e-06	4.22e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—AKT1—uterine cancer	2.66e-06	3.96e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CA—uterine cancer	2.65e-06	3.94e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—AKT1—uterine cancer	2.64e-06	3.94e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PTEN—uterine cancer	2.47e-06	3.69e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—AKT1—uterine cancer	2.37e-06	3.53e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—EP300—uterine cancer	2.36e-06	3.52e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—AKT1—uterine cancer	2.31e-06	3.45e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CA—uterine cancer	2.26e-06	3.37e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—AKT1—uterine cancer	2.16e-06	3.22e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—AKT1—uterine cancer	1.85e-06	2.75e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.74e-06	2.6e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AKT1—uterine cancer	1.43e-06	2.12e-05	CbGpPWpGaD
